MET gene copy number heterogeneity in non-small cell lung cancer patients resistant to EGFR-TKIs

被引：0
|
作者：
Bai, Q. [1 ]
Chen, Y. [1 ]
Xiao, X. [2 ]
Chang, H. [1 ]
Xin, B. [2 ]
Jia, L. [1 ]
Li, J. [2 ]
Wang, Z. [1 ]
Yu, C. [1 ]
Xiong, H. [3 ]
Zhou, X. [1 ]
机构：
[1] Fudan Univ, Pathol, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Shanghai Yuanqi Biomed Technol Co Ltd, Shanghai, Peoples R China
[3] Shanghai Rightongene Biotechnol Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
203P
引用
收藏
页码：S150 / S151
页数：2
相关论文
共 50 条
  • [1] The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer
    Zhao, Dan
    Chen, Xuejing
    Qin, Na
    Su, Dan
    Zhou, Lijuan
    Zhang, Quan
    Li, Xi
    Zhang, Xinyong
    Jin, Mulan
    Wang, Jinghui
    SCIENTIFIC REPORTS, 2017, 7
  • [2] The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer
    Dan Zhao
    Xuejing Chen
    Na Qin
    Dan Su
    Lijuan Zhou
    Quan Zhang
    Xi Li
    Xinyong Zhang
    Mulan Jin
    Jinghui Wang
    Scientific Reports, 7
  • [3] ANALYSIS OF THE EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER PATIENTS AFTER EGFR-TKIS TREATMENT
    Matsuo, Midori
    Nanae, Tomonaga
    Koichi, Izumikawa
    Hiroyuki, Yamaguchi
    Takaya, Ikeda
    Katsumi, Nakatomi
    Yoichi, Nakamura
    Kazuhiro, Tsukamoto
    Shigeru, Kohno
    RESPIROLOGY, 2010, 15 : 68 - 68
  • [4] MET Amplification Predicts Primary Resistance to EGFR-TKIs in Advanced Non-Small Cell Lung Cancer Patients with Sensitive EGFR Mutation
    Fang, L.
    Lu, X.
    Hu, S.
    Tang, Z.
    Luthra, R.
    Routbort, M.
    Patel, K.
    Wang, R.
    Broaddus, R.
    Chen, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1032 - 1032
  • [5] Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
    Yu, Yinan
    Zhao, Jianguo
    Xu, Jiaona
    Bai, Rui
    Gu, Zewei
    Chen, Xialin
    Wang, Jianfang
    Jin, Xueying
    Gu, Gaoyang
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (12) : 1889 - 1916
  • [6] Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
    Yinan Yu
    Jianguo Zhao
    Jiaona Xu
    Rui Bai
    Zewei Gu
    Xialin Chen
    Jianfang Wang
    Xueying Jin
    Gaoyang Gu
    Current Treatment Options in Oncology, 2023, 24 : 1935 - 1947
  • [7] COMPARISON OF EGFR-TKIS AND PEMETREXED FOR KOREAN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Lee, J. H.
    Ryu, Y. J.
    Chun, E. M.
    Chang, J. H.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S90 - S90
  • [8] Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer
    Hu, Wentao
    Liu, Yahui
    Chen, Jian
    ONCOTARGET, 2017, 8 (15) : 25046 - 25054
  • [9] Clinical efficacy and safety of apatinib combined with EGFR-TKIs in advanced non-small cell lung cancer with EGFR-TKIs resistance
    Tian, Ruifen
    Guo, Yi
    Zhang, Xia
    Zhang, Xing
    Guo, Wei
    Zhu, Haibo
    Xu, Junjun
    Shen, Fangfang
    Song, Xia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Safety of EGFR-TKIs for EGFR mutation-positive non-small cell lung cancer
    Zhou, Jia-Ying
    Liu, Si-Yang
    Wu, Yi-Long
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (05) : 589 - 599
12345